Literature DB >> 200294

[Isoenzyme pattern of acid phosphatase in epstein-barr-virus-DNA positive permanent growing lymphoid cell lines (author's transl)].

H W Heyden, R Weber, H Stuckstedte, J G Saal, K O Fresen.   

Abstract

The expression of acid phosphatases is cytochemically one of the most important features in permanent growing B-cell-lines. In few cell lines acid phosphatase is resistant against tartrate. Tartrate resistant isoenzyme 5 with components a and b can be demonstrated in monocytes, lymphocytes, chronic lymphatic leucemic cells and especially in hairy cells as well as in cell lines derived from a healthy donor. Fractionation of acid phosphatase by gelelectrophoresis in separated lymphocytes demonstrates especially isoenzyme 3, in separated macrophages isoenzyme 4. Isoenzyme 4 could not be detected in several cell lines. It is therefore concluded that these cell lines are probably derived from lymphocytic precursors. Cell lines with isoenzyme 4 may be the result of a facultative hybridisation between lymphocytes and monocytes. Profiles of acid phosphatases in virus-negative cell lines (Ramos, BJAB) were not significantly altered by conversion with EBV.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 200294     DOI: 10.1007/bf00996626

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  22 in total

1.  Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains.

Authors:  K O Fresen; H Hausen
Journal:  Int J Cancer       Date:  1976-02-15       Impact factor: 7.396

2.  An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.

Authors:  G Klein; B Giovanella; A Westman; J S Stehlin; D Mumford
Journal:  Intervirology       Date:  1975       Impact factor: 1.763

Review 3.  Cell relationships in transformation of human leukocytes by Epstein-Barr virus.

Authors:  J H Pope; W Scott; D J Moss
Journal:  Int J Cancer       Date:  1974-07-15       Impact factor: 7.396

4.  Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus.

Authors:  G Klein; L Dombos; B Gothoskar
Journal:  Int J Cancer       Date:  1972-07-15       Impact factor: 7.396

5.  Acid phosphatase isoenzyme in human leukocytes in normal and pathologic conditions.

Authors:  C Y Li; L T Yam; K W Lam
Journal:  J Histochem Cytochem       Date:  1970-07       Impact factor: 2.479

6.  Epstein-Barr virus-induced transformation of human leukocytes after cell fractionation.

Authors:  U Schneider; H zur Hausen
Journal:  Int J Cancer       Date:  1975-01-15       Impact factor: 7.396

7.  Cell-mediated cytotoxicity for melanoma tumor cells: detection by a (3H) proline release assay.

Authors:  J G Saal; E P Rieber; G Riethmüller
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

8.  Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas.

Authors:  G Klein; T Lindahl; M Jondal; W Leibold; J Menézes; K Nilsson; C Sundström
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

9.  Isozymes of acid phosphatase in normal and Calmette-Guérin bacillus-induced rabbit alveolar macrophages.

Authors:  S G Axline
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

10.  Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes.

Authors:  M Jondal; G Klein
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.